Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-06-20
1989-05-02
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530385, 424101, A61K 3714, C07K 308, C07K 1522
Patent
active
048268119
ABSTRACT:
An acellular red blood cell substitute which comprises an essentially tetramer-free, substantially stroma-free, cross-linked, polymerized, pyridoxylated hemoglobin and a nontoxic, pharmaceutically acceptable carrier, its use and a process for preparing said acellular red blood cell substitute.
REFERENCES:
patent: 4001200 (1977-01-01), Bonsen et al.
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4136093 (1979-01-01), Bonhard et al.
patent: 4526715 (1985-07-01), Kothe et al.
patent: 4529719 (1985-07-01), Tye
DeVenuto et al., J. Surg. Res., 34, 205-212 (1983).
Friedman et al., cited in Biol. Abstracts 79(5) 43028, 1984.
Klein, cited in Chem. Abstracts, vol. 79:398072, 1973.
De Woskin Richard E.
Gould Steven A.
Moss Gerald S.
Rosen Arthur L.
Sehgal Hansa
Brown Johnnie R.
Northfield Laboratories, Inc.
Stone Jacqueline M.
LandOfFree
Acellular red blood cell substitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acellular red blood cell substitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acellular red blood cell substitute will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-584983